s

selectION Therapeutics

10 employees

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Pharmaceutical

Date founded

2017

Funding rounds raised

Total raised

$4.1M

from 2 investors over 2 rounds

s

selectION Therapeutics raised $4.1M on May 31, 2019

Investors: Sdl Ventures and Global Source Ventures, LLC

FAQ